Concepedia

Bo Fu

BF

Statistics

Publications

3

Citations

166

H-Index

3

Active since

2021

Affiliations

GlaxoSmithKline (Belgium)(Current)

Sanofi (France)

Sanofi (United States)

Fred Hutch Cancer Center

University of Alabama at Birmingham

Bo Fu is an author at GlaxoSmithKline (Belgium) specializing in vaccination, immunology, and vaccine immunology.

ORCID

Publications per year

2021–2022

3

Publications

3

Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study

Paul Goepfert, Bo Fu, Anne-Laure Chabanon et al. · The Lancet Infectious Diseases · 2021 · 123 citations · Full text

, , +14

Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant protein vaccine candidate

Stephen C. De Rosa, Kristen W. Cohen, Matthew Bonaparte et al. · Clinical & Translational Immunology · 2022 · 28 citations · Full text

, , +16

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine

Gustavo H. Dayan, Nadine Rouphael, Stephen R. Walsh et al. · medRxiv · 2022 · 15 citations · Full text

, , +17

1–3 of 3